484 related articles for article (PubMed ID: 35959366)
21. Fusobacterium and Enterobacteriaceae: important players for CRC?
Allen-Vercoe E; Jobin C
Immunol Lett; 2014 Dec; 162(2 Pt A):54-61. PubMed ID: 24972311
[TBL] [Abstract][Full Text] [Related]
22. Macrophage interactions with fungi and bacteria in inflammatory bowel disease.
Leonardi I; Li X; Iliev ID
Curr Opin Gastroenterol; 2018 Nov; 34(6):392-397. PubMed ID: 30239343
[TBL] [Abstract][Full Text] [Related]
23. Role of intestinal microbiota and metabolites on gut homeostasis and human diseases.
Lin L; Zhang J
BMC Immunol; 2017 Jan; 18(1):2. PubMed ID: 28061847
[TBL] [Abstract][Full Text] [Related]
24. The Microbiome in Patients With Inflammatory Diseases.
Somineni HK; Kugathasan S
Clin Gastroenterol Hepatol; 2019 Jan; 17(2):243-255. PubMed ID: 30196163
[TBL] [Abstract][Full Text] [Related]
25. The Role of Gut Microbiota and Metabolites in Obesity-Associated Chronic Gastrointestinal Disorders.
Islam MR; Arthur S; Haynes J; Butts MR; Nepal N; Sundaram U
Nutrients; 2022 Jan; 14(3):. PubMed ID: 35276983
[TBL] [Abstract][Full Text] [Related]
26. Gut microbiota in the pathogenesis of inflammatory bowel disease.
Nishida A; Inoue R; Inatomi O; Bamba S; Naito Y; Andoh A
Clin J Gastroenterol; 2018 Feb; 11(1):1-10. PubMed ID: 29285689
[TBL] [Abstract][Full Text] [Related]
27. Review article: bugs, inflammation and mood-a microbiota-based approach to psychiatric symptoms in inflammatory bowel diseases.
Thomann AK; Mak JWY; Zhang JW; Wuestenberg T; Ebert MP; Sung JJY; Bernstein ÇN; Reindl W; Ng SC
Aliment Pharmacol Ther; 2020 Jul; 52(2):247-266. PubMed ID: 32525605
[TBL] [Abstract][Full Text] [Related]
28. Current understanding of microbiota- and dietary-therapies for treating inflammatory bowel disease.
Eom T; Kim YS; Choi CH; Sadowsky MJ; Unno T
J Microbiol; 2018 Mar; 56(3):189-198. PubMed ID: 29492876
[TBL] [Abstract][Full Text] [Related]
29. Intestinal microbiota pathogenesis and fecal microbiota transplantation for inflammatory bowel disease.
Wang ZK; Yang YS; Chen Y; Yuan J; Sun G; Peng LH
World J Gastroenterol; 2014 Oct; 20(40):14805-20. PubMed ID: 25356041
[TBL] [Abstract][Full Text] [Related]
30. The Gut Microbiome and Inflammatory Bowel Diseases.
Shan Y; Lee M; Chang EB
Annu Rev Med; 2022 Jan; 73():455-468. PubMed ID: 34555295
[TBL] [Abstract][Full Text] [Related]
31. Organoid-based Models to Study the Role of Host-microbiota Interactions in IBD.
Poletti M; Arnauts K; Ferrante M; Korcsmaros T
J Crohns Colitis; 2021 Jul; 15(7):1222-1235. PubMed ID: 33341879
[TBL] [Abstract][Full Text] [Related]
32. The Interplay between Immune System and Microbiota in Inflammatory Bowel Disease: A Narrative Review.
Aldars-García L; Marin AC; Chaparro M; Gisbert JP
Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33802883
[TBL] [Abstract][Full Text] [Related]
33. Gut Microbiota and Alimentary Tract Injury.
Chen Y; Wu G; Zhao Y
Adv Exp Med Biol; 2020; 1238():11-22. PubMed ID: 32323177
[TBL] [Abstract][Full Text] [Related]
34. Fecal Microbiota and Metabolome in a Mouse Model of Spontaneous Chronic Colitis: Relevance to Human Inflammatory Bowel Disease.
Robinson AM; Gondalia SV; Karpe AV; Eri R; Beale DJ; Morrison PD; Palombo EA; Nurgali K
Inflamm Bowel Dis; 2016 Dec; 22(12):2767-2787. PubMed ID: 27824648
[TBL] [Abstract][Full Text] [Related]
35. Interplay of host genetics and gut microbiota underlying the onset and clinical presentation of inflammatory bowel disease.
Imhann F; Vich Vila A; Bonder MJ; Fu J; Gevers D; Visschedijk MC; Spekhorst LM; Alberts R; Franke L; van Dullemen HM; Ter Steege RWF; Huttenhower C; Dijkstra G; Xavier RJ; Festen EAM; Wijmenga C; Zhernakova A; Weersma RK
Gut; 2018 Jan; 67(1):108-119. PubMed ID: 27802154
[TBL] [Abstract][Full Text] [Related]
36. Gut microbiome dysbiosis in inflammatory bowel disease.
Lal S; Kandiyal B; Ahuja V; Takeda K; Das B
Prog Mol Biol Transl Sci; 2022; 192(1):179-204. PubMed ID: 36280319
[TBL] [Abstract][Full Text] [Related]
37. Role of intestinal microbiota and metabolites in inflammatory bowel disease.
Dong LN; Wang M; Guo J; Wang JP
Chin Med J (Engl); 2019 Jul; 132(13):1610-1614. PubMed ID: 31090547
[TBL] [Abstract][Full Text] [Related]
38. The Emerging Role of Bile Acids in the Pathogenesis of Inflammatory Bowel Disease.
Thomas JP; Modos D; Rushbrook SM; Powell N; Korcsmaros T
Front Immunol; 2022; 13():829525. PubMed ID: 35185922
[TBL] [Abstract][Full Text] [Related]
39. Antibiotic-associated dysbiosis affects the ability of the gut microbiota to control intestinal inflammation upon fecal microbiota transplantation in experimental colitis models.
Strati F; Pujolassos M; Burrello C; Giuffrè MR; Lattanzi G; Caprioli F; Troisi J; Facciotti F
Microbiome; 2021 Feb; 9(1):39. PubMed ID: 33549144
[TBL] [Abstract][Full Text] [Related]
40. Opportunistic detection of Fusobacterium nucleatum as a marker for the early gut microbial dysbiosis.
Huh JW; Roh TY
BMC Microbiol; 2020 Jul; 20(1):208. PubMed ID: 32660414
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
